Bank of Montreal Can Raises Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Bank of Montreal Can boosted its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 309.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 267,394 shares of the real estate investment trust's stock after acquiring an additional 202,131 shares during the period. Bank of Montreal Can owned 0.10% of Omega Healthcare Investors worth $10,784,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in OHI. Versant Capital Management Inc purchased a new position in Omega Healthcare Investors during the 2nd quarter valued at about $26,000. UMB Bank n.a. grew its holdings in Omega Healthcare Investors by 353.4% during the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 516 shares in the last quarter. DiNuzzo Private Wealth Inc. purchased a new position in Omega Healthcare Investors during the 3rd quarter valued at about $33,000. V Square Quantitative Management LLC grew its holdings in Omega Healthcare Investors by 49.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust's stock valued at $40,000 after buying an additional 323 shares in the last quarter. Finally, Truvestments Capital LLC purchased a new position in Omega Healthcare Investors during the 3rd quarter valued at about $43,000. Hedge funds and other institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Stock Performance

NYSE OHI traded down $0.46 during trading hours on Monday, hitting $40.15. The company's stock had a trading volume of 392,128 shares, compared to its average volume of 1,680,982. The company's 50 day simple moving average is $40.61 and its two-hundred day simple moving average is $37.40. The company has a market cap of $10.84 billion, a P/E ratio of 29.68, a price-to-earnings-growth ratio of 1.26 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $44.42. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48.

Omega Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.67%. Omega Healthcare Investors's dividend payout ratio is currently 197.06%.

Insider Buying and Selling at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company's stock, valued at $7,357,824.44. The trade was a 10.96 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on OHI. Scotiabank lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a report on Monday, August 26th. BNP Paribas upgraded shares of Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 target price for the company in a research report on Thursday, October 31st. Wells Fargo & Company reissued an "overweight" rating and issued a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. BMO Capital Markets lifted their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a "market perform" rating in a report on Monday, October 7th. Finally, Truist Financial upped their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a report on Wednesday, September 4th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $40.00.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.